The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashokkumar Vijaysinh Barot
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ashokkumar Vijaysinh Barot, identified as part of the promoter/promoter group of Senores Pharmaceuticals, acquired 1,000 equity shares in the open market on August 28, 2025. This is a routine disclosure filed under Regulation 29(2) of SEBI's SAST Regulations. His holding rose marginally from 3,443,866 shares (7.48%) to 3,444,866 shares (7.48%) post-acquisition, with the change in percentage rounding to 0.00%. The acquisition is very small in quantum compared to his existing stake, suggesting a routine or symbolic purchase rather than a strategic stake build-up. Senores Pharmaceuticals has a total equity share capital of 46,053,588 shares of Rs. 10 each.
Negligible impact on the overall shareholding pattern or float; the purchase size is too small to materially affect promoter control or stock price. Mildly positive as it shows a promoter is continuing to buy on the market, but the tiny size means it carries limited conviction signal for retail investors.